NovaBay Pharmaceuticals Issues Letter to Stockholders

by Business Wire • 2020/05/14 • 0 Comments

EMERYVILLE, Calif.--(BUSINESS WIRE)-- #NovaBay--NovaBay Pharmaceuticals CEO Justin Hall issues Letter to Stockholders

← New textile coating prevents viruses from adhering to the surface

New Data on the Pharmacokinetic Profile of TEPEZZA™ (teprotumumab-trbw) Reinforce the Labeled Dosing Regimen, Indicating a Positive, Consistent Response to Therapy →